Blog

Jasmine Kamboj: Access to oncological drugs and clinical trials – US vs LMICs

Jasmine Kamboj/X

Mar 27, 2025, 13:57

Jasmine Kamboj: Access to oncological drugs and clinical trials – US vs LMICs

Jasmine Kamboj, Medical Oncologist and Hematologist at Mayo Clinic, shared a post on LinkedIn:

“Please join for the CPOEM Foundation and American Society of Clinical Oncology (ASCO) webinar on “Access to oncological drugs and clinical trials- US vs LMICs”.

3/28/25, 7:00 PM to 8:30 PM IST.

Stellar speakers like Robin Zon, Gilberto de lima Lopes Junior, Rachan Shetty KS, Dr. Vishwanath Sathyanarayanan, Jason Westin, Guru Sonpavde, Maryam Lustberg, Fredrick Chite Asirwa.

Thanks ASCO and CPOEM for this opportunity.”

Jasmine Kamboj: Access to oncological drugs and clinical trials - US vs LMICs

More posts featuring Jasmine Kamboj.

American Society of Clinical Oncology ASCO cancer clinical trials CPOEM Foundation Dr. Vishwanath Sathyanarayanan fight against cancer Fredrick Chite Asirwa Gilberto de Lima Lopes Junior Global fight against cancer Guru Sonpavde Jasmine Kamboj Jason Westin LMICs Maryam Lustberg Mayo Clinic MedOnc OncoDaily oncological drugs Oncology Rachan Shetty KS Robin Zon US

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action